Efficacy, PK and safety results of a Phase I/II clinical study of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in previously treated patients with haemophilia B - Martinowitz, U (J Thromb Haemost, 2013)
(Abstract OC 70.2).